Extracellular signal-regulated kinase 1/extracellular signal-regulated kinase 2 mitogen-activated protein kinase signaling and activation of activator protein 1 and nuclear factor κB transcription factors play central roles in interleukin-8 expression stimulated by monosodium urate monohydrate and calcium pyrophosphate crystals in monocytic cells

Arthritis and Rheumatism

Volumn 43, Issue 5, 2000, Pages 1145-1155

  Liu, Ru ^a   O'Connell, Maria ^b   Johnson, Kristen ^a   Pritzker, Kenneth ^c   Mackman, Nigel ^b   Terkeltaub, Robert ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

^d VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM PYROPHOSPHATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; URATE;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; GOUT; HUMAN; HUMAN CELL; MONONUCLEAR PHAGOCYTE; PRIORITY JOURNAL; PROTEIN DNA BINDING; PSEUDOGOUT; SIGNAL TRANSDUCTION;

CALCIUM PYROPHOSPHATE; HUMANS; INTERLEUKIN-8; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; MONOCYTES; NF-KAPPA B; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR AP-1; URIC ACID;

EID: 0034124956     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(200005)43:5<1145::AID-ANR25>3.0.CO;2-T     Document Type: Article

References (59)

1. Terkeltaub R. Pathogenesis and treatment of crystal-induced inflammation. In: Koopman WJ, editor. Arthritis and allied conditions, 13th ed. Baltimore: Williams and Wilkins; 1996. p. 2085-102.
2. Phelps P, McCarty DJ. Crystal induced inflammation in canine joints. II. Importance of polymorphonuclear leukocytes. J Exp Med 1996;124:115-26.
3. Terkeltaub R, Baird S, Sears P, Santiago R, Boisvert W. The murine homolog of the interleukin-8 receptor CXCR-2 is essential for the occurrence of neutrophilic inflammation in the air pouch model of acute unite crystal-induced gouty synovitis. Arthritis Rheum 1998;41:900-9.
4. Nishimura A, Akahoshi T, Takahashi M, Takagishi K, Itomari M, Kondo H, et al. Attenuation of monosodium urate crystal-induced arthritis in rabbits by a neutralizing antibody against interleukin-8. J Leukoc Biol 1997;62:444-9.
5. Terkeltaub R, Zachariae C, Santoro D, Martin J, Peveri P, Matsushima K. Monocyte-derived neutrophil chemotactic factor/ interleukin-8 is a potential mediator of crystal-induced inflammation. Arthritis Rheum 1991;34:894-903.
6. Miller EJ, Brelsford WG. Interleukin 8: the major neutrophil chemotaxin in a case of pseudogout. J Rheumatol 1993;20:1250-1.
7. Hoch RC, Schraufstatter IU, Cochrane CG. In vivo, in vitro, and molecular aspects of interleukin-8 and the intcrleukin-8 receptors. J Lab Clin Med 1996;128:134-45.
8. Detmers PA, Lo SK, Olsen-Egbert E, Walz A, Baggiolini M, Cohn ZA. Neutrophil-activating protein 1/interleukin 8 stimulates the binding activity of the leukocyte adhesion receptor CD1 1b/CD18 on human neutrophils. J Exp Med 1990;171:1155-62.
9. Matsukawa A, Yoshimura T, Maeda T, Ohkawara S, Takagi K, Yoshinaga M. Neutrophil accumulation and activation by homologous IL-8 in rabbits: IL-8 induces destruction of cartilage and production of IL-1 and IL-1 receptor antagonist in vivo. J Immunol 1995;154:5418-25.
10. Mukaida N, Okamoto S, Ishikawa Y, Matsushima K. Molecular mechanism of interleukin-8 gene expression. J Leukoc Biol 1994; 56:554-8.
11. Akira S, Kishimoto T. NF-IL6 and NF-kappa B in cytokine gene regulation. Adv Immunol 1997;65:1-46.
12. Matsusaka T, Fujikawa K, Nishio Y, Mukaida N, Matsushima K, Kishimoto T, et al. Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc Natl Acad Sci U S A 1993;90:10193-7.
13. McCarthy GM, Augustine JA, Baldwin AS, Christopherson PA, Cheung HS, Westfall PR, et al. Molecular mechanism of basic calcium phosphate crystal-induced activation of human fibroblasts: role of nuclear factor kappa b, activator protein 1, and protein kinase c. J Biol Chem 1998;273:35161-9.
14. Karin M. The regulation of AP-1 activity by mitogen-activatcd protein kinases. Philos Trans R Soc Lond B Biol Sci 1996;351:127-34.
15. Karin M. Mitogen-activated protein kinase cascades as regulators of stress responses. Ann N Y Acad Sci 1998;851:139-46.
16. Whitmarsh AJ, Davis RJ. Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J Mol Med 1996;74:589-607.
17. Xu S, Cobb MH. MEKK1 binds directly to the c-Jun N-terminal kinase s/stress-activated protein kinases. J Biol Chem 1997;272: 32056-60.
18. Frost JA, Steen H, Shapiro P, Lewis T, Ahn N, Shaw PE, et al. Cross-cascade activation of ERKs and ternary complex factors by Rho family proteins. EMBO J 1997;16:6426-38.
19. Minden A, Lin A, Smeal T, Derijard B, Cobb M, Davis R, et al. c-Jun N-terminal phosphorylation correlates with activation of the JNK subgroup but not the ERK subgroup of mitogen-activated protein kinases. Mol Cell Biol 1994;14:6683-8.
20. Minden A, Karin M. Regulation and function of the JNK subgroup of MAP kinases. Biochim Biophys Acta 1997;1333:F85-104.
21. Fuchs SY, Xie B, Adler V, Fried VA, Davis RJ, Ronai Z. c-Jun NH2-terminal kinases target the ubiquitination of their associated transcription factors. J Biol Chem 1997;272:32163-8.
22. Musti AM, Treier M, Bohmann D. Reduced ubiquitin-dependent degradation of c-Jun after phosphorylation by MAP kinases. Science 1997;275:400-2.
23. Terkeltaub R, Sklar LA, Mueller H. Neutrophil activation by inflammatory microcrystals of monosodium urate monohydrate utilizes pertussis toxin-insensitive and sensitive pathways. J Immunol 1990;144:2719-24.
24. Onello E, Kaplan A, Sklar L, Terkeltaub R. Mechanism of neutrophil activation by an unopsonized inflammatory particulate: urate crystals induce pertussis toxin-insensitive hydrolysis of phosphatidylinositol 4,5-bisphosphate. J Immunol 1991;146:4289-99.
25. Bomalaski JS, Baker DG, Brophy LM, Clark MA. Monosodium urate crystals stimulate phospholipase A2 enzyme activities and the synthesis of a phospholipase A2-activating protein. J Immunol 1990;145:3391-7.
26. Gaudry M, Gilbert C, Poubelle PE, Naccache PH. Activation of Lyn is a common element of stimulation of neutrophils by soluble and particulate agonists. Blood 1995;86:3567-74.
27. Roberge C, Gaudry M, Medicis R, Lussier A, Poubelle P, Naccache P. Crystal-induced neutrophil activation. IV. Specific inhibition of tyrosine phosphorylation by colchicine. J Clin Invest 1993;92:17223-9.
28. Bomalaski JS, Baker DG, Brophy LM, Clark MA. Monosodium urate crystals stimulate phospholipase A2 enzyme activities and the synthesis of a phospholipase A2-activating protein. J Immunol 1990;145:3391-7.
29. Marcil J, Harbour D, Houle MG, Naccache PH, Bourgoin S. Monosodium urate-crystal-stimulated phospholipase D in human neutrophils. Biochem J 1999;337:185-92.
30. Nair D, Misra RP, Sallis JD, Cheung HS. Phosphocitrate inhibits a basic calcium phosphate and calcium pyrophosphate dihydrate crystal-induced mitogen-activated protein kinase cascade signal transduction pathway. J Biol Chem 1997;272:18920-5.
31. Tudan C, Jackson JK, Charlton L, Pelech SL, Sahl B, Burt HM. Activation of S6 kinase in human neutrophils by calcium pyrophosphate dihydrate crystals: protein kinase C-dependent and phosphatidylinositol-3-kinase-independent pathways. Biochem J 1998;331:531-7.
32. Pouliot M, James MJ, McColl SR, Naccache PH, Cleland LG. Monosodium urate microcrystals induce cyclooxygenase-2 in human monocytes. Blood 1998;91:1769-76.
33. Cheng PT, Pritzker KP. The effect of calcium and magnesium ions on calcium pyrophosphate crystal formation in aqueous solutions. J Rheumatol 1981;8:772-82.
34. Beeston BEP, Home RW, Markham R. Electron diffraction and optical diffraction techniques. New York: North-Holland; 1973.
35. Chandler JA. X-ray microanalysis in the electron microscope. New York: North-Holland; 1977.
36. Mackman N, Brand K, Edgington TS. Lipopolysaccharide-mediated transcriptional activation of the human tissue factor gene in THP-1 monocytic cells requires both activator protein 1 and nuclear factor kappa B binding sites. J Exp Med 1991;174: 1517-26.
37. Wiik P, Haugen AH, Lovhaug D, Boyum A, Opstad PK. Effect of VIP on the respiratory burst in human monocytes ex vivo during prolonged strain and energy deficiency. Peptides 1989;10:819-23.
38. Mastronarde JG, Monick MM, Mukaida N, Matsushima K, Hunninghake GW. Activator protein-1 is the preferred transcription factor for cooperative interaction with nuclear factor-kappaB in respiratory syncytial virus-induced interleukin-8 gene expression in airway epithelium. J Infect Dis 1998;177:1275-81.
39. Terkeltaub R, Johnson K, Rohnow D, Goomer R, Burton DW, Deftos LJ. Bone morphogenetic proteins and bFGF exert opposing regulatory effects on PTHrP expression and inorganic pyrophosphate elaboration in immortalized murine endochondral hypertrophic chondrocytes. J Bone Miner Res 1998;13:931-41.
40. Kunsch C, Lang RK, Rosen CA, Shannon MF. Synergistic transcriptional activation of the IL-8 gene by NF-kappa B p65 (RelA) and NF-IL-6. J Immunol 1994;153:153-64.
41. Boehm JC, Smietana JM, Sorenson ME, Garigapati RS, Gallagher TF, Sheldrake PL, et al. 1-substituted 4-aryl-5-pyridinylimidazoles: a new class of cytokine suppressive drugs with low 5-lipoxygenase and cyclooxygenase inhibitory potency. J Med Chem 1996;39: 3929-37.
42. Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase in vitro and in vivo. J Biol Chem 1995;270:27489-94.
43. Mackman N. Protease inhibitors block lipopolysaccharide induction of tissue factor gene expression in human monocytic cells by preventing activation of c-rel/p65 heterodimers. J Biol Chem 1994;269:26363-7.
44. Dean JL, Brook M, Clark AR, Saklatvala J. p38 mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes. J Biol Chem 1999;274:264-9.
45. Swantck JL, Cobb MH, Geppert TD. Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor alpha (TNF-alpha) translation: glucocorticoids inhibit TNF-alpha translation by blocking JNK/SAPK. Mol Cell Biol 1997;17:6274-82.
46. Di Giovine FS, Malawista SE, Nuki G, Duff GW. Interleukin 1 (IL-1) as a mediator of crystal arthritis: stimulation of T cell and synovial mitogenesis by urate crystal-induced IL-1. J Immunol 1987;138:3213-8.
47. Di Giovine FS, Malawista SE, Thornton E, Duff GW. Urate crystals stimulate production of TNFα from human blood monocytes and synovial cells. J Clin Invest 1991;87:1375-81.
48. Cuenda A, Cohen P, Buee-Scherrer V, Goedert M. Activation of stress-activated protein kinase-3 (SAPK3) by cytokines and cellular stresses is mediated via SAPKK3 (MKK6); comparison of the specificities of SAPK3 and SAPK2 (RK/p38). EMBO J 1997;16: 295-305.
49. Hazzalin CA, Cano E, Cuenda A, Barratt MJ, Cohen P, Mahadevan LC. p38/RK is essential for stress-induced nuclear responses: JNK/SAPKs and c-Jun/ATF-2 phosphorylation are insufficient. Curr Biol 1996;1:1028-31.
50. Cheung HS, Sallis JD, Struve JA. Specific inhibition of basic calcium phosphate and calcium pyrophosphate crystal-induction of metalloproteinase synthesis by phosphocitrate. Biochim Biophys Acta 1996;1315:105-11.
51. Barabe F, Gilbert C, Liao N, Bourgoin SG, Naccache PH. Crystal-induced neutrophil activation. VI. Involvement of FcgammaRIIIB (CD16) and CD11b in response to inflammatory microcrystals. FASEB J 1998;12:209-20.
52. Lin L-L, Wartmann M, Lin AY, Knopf KL, Seth A, Davis RJ. cPLA2 is phosphorylated and activated by MAP kinase. Cell J 1993;72:269-78.
53. Xing J, Ginty DD, Greenberg ME. Coupling of the RAS-MAPK pathway to gene activation by RSK2, a growth factor-regulated CREB kinase. Science 1996;273:959-63.
54. Ghoda L, Lin X, Greene WC. The 90-kDa ribosomal S6 kinase (pp90rsk) phosphorylates the N-terminal regulatory domain of Iκβα and stimulates its degradation in vitro. J Biol Chem 1997; 272:21281-8.
55. Lin T-A, Kong X, Haystead TAJ, Pause A, Belsham G, Sonenberg N, et al. PHAS-I as a link between mitogen-activated protein kinase and translation initiation. Science 1994;266:653-6.
56. McLaughlin MM, Kumar S, McDonnell PC, van Horn S, Lee JC, Livi GP, et al. Identification of mitogen-activated protein (MAP) kinase-activated protein kinase-3, a novel substrate of CSBP p38 MAP kinase. J Biol Chem 1996;271:8488-92.
57. New L, Jiang M, Liu K, Zhu W, Flood LJ, Kato Y, et al. PRAK, a novel protein kinase regulated by the p38 MAP kinase. EMBO J 1998;17:3372-84.
58. Lee FS, Peters RT, Dang LC, Maniatis T. MEKK1 activates both I-kappa-B kinase alpha and I-kappa-B kinase beta. Proc Natl Acad Sci U S A 1998;95:9319-24.
59. Chen CY, Del Gatto-Konczak F, Wu Z, Karin M. Stabilization of interleukin-2 mRNA by the c-Jun NH2-terminal kinase pathway. Science 1998;280:1945-9.